Ramadan Mubarak to all! May this month be a time of reflection, prayer, and spiritual growth.

May this Gudi Padwa bring you a new spirit, new beginning and new prosperity.

Hon'ble President of India officially launches & dedicates NexCAR19 to the Nation.

We're honored to announce that Immunoact has been recognized with the prestigious award for Outstanding Achievement in Immunotherapy at Precision Med India 2024. This recognition is a testament to our dedication to advancing healthcare through innovative CAR-T cell therapies

Another significant step towards providing comprehensive access to world's most affordable CAR-T cell therapies NexCAR19 and our pipeline CAR-T cell therapies, we are pleased to announce a commercial collaboration with Zydus Hospitals , Gujarat.

As we immerse ourselves in the colors of Holi, let's also immerse ourselves in the spirit of teamwork, cooperation, and mutual respect. Wishing you a #HappyHoli filled with productive collaborations and successful outcomes.

We are pleased to announce a collaboration with Jehangir Hospital, Pune to provide NexCAR19, India's first market authorized CAR-T cell therapy to patients with refractory/relapsing B-cell lymphomas and acute lymphoblastic leukaemia.

We've been featured on The Morning Brief - The Economic Times podcast - hosted by Anirban Chowdhury with ET's Vikas Dandekar.

Click on the link to listen to the podcast!
economictimes.indiatimes.com/news/morning-b…

NexCAR19 sought to revolutionize the standard of care in improving outcomes of patients with r/r B-cell cancers. An article by Devina Sengupta of Mint highlights its journey from concept to clinic and beyond. Our goal now, is to expand access & affordability to the masses.

NexCAR19, developed by IIT Bombay & ImmunoACT has received the prestigious The Galien Foundation award for the Best Product for Rare/Orphan Diseases in India. Rahul Purwar, was presented the award on 29th Feb. 2024 by the Hon'ble Health Minister of State Prof. SP Singh Baghel

Unlocking Clinical Insights: Join Gaurav Narula MD as he dives into real-world case studies, revealing strategies to tackle post CAR-T infusion toxicities.

Date - 7th March 2024, at 04:30 PM
Link for webinar - us06web.zoom.us/j/86578710577?…

A recent Hindustan Times article highlights NexCAR19’s journey from an internet search to India’s gene-modified cell therapy. Read how the idea to indigenize a CAR-T platform was made into reality by Rahul Purwar - IIT Bombay & Gaurav Narula MD - Tata Memorial Hospital

msn.com/en-in/health/h…

Along with our strategic investor-partner Laurus Labs we represented NexCAR19 and our fully integrated and indigenized CAR-T platform at BioAsia 2024 to industry leaders from across the region, in Hyderabad.

Our Co-Founder & Head of Scientific Affairs, Atharva Karulkar highlighted our CAR-T platform which is now commercially approved for treating certain rare B-cell cancers, to representatives including Dr. V K Paul, Member NITI Ayog, & Bill Gates of the Bill & Melinda Gates Foundation

Special thanks to Nikita Mehra Parathan Karunakaran Venky (Venkatraman Radhakrishnan) and Dr. Krishnarathinam Kannan at Cancer Institute (WIA), Chennai!

Today is Rare Disease Day.

It's important to recognize, spread awareness, and enable access for the over 300 million people globally who are affected by a rare disease.

We are glad to have taken a significant step in providing our CAR-T cell therapies affordably and expandably across India, in collaboration with one of the country's earliest & foremost cancer care centres, Cancer Institute (WIA), Chennai

Pleasure to be hosted by one of the earliest & prominent Bone Marrow Transplant centres in the country at Apollo Cancer Centre, Chennai Centre, Chennai. Special thanks to Dr. T. Raja and the entire team for an excellent engagement and charting a way for the future of #cartcelltherapy in India.

Thanks to the entire Apollo Proton Cancer Centre | #WinningOverCancer Cancer Centre, Chennai team for hosting us and an interesting exchange of ideas on how we can leverage #cartcelltherapy together for the greater good of patients in India and beyond
Special thanks to Karan Puri, Dr Jose Easow, Dr. Prasad Eswaran